Abstract
It is important in heart transplantation to evaluate precisely the extent and location of cardiac rejection. At present, right ventricular endomyocardial biopsy has been used as the gold standard, however, establishment of noninvasive, simple, and easy diagnostic procedure is desired. The canine donor heart, in which atrial septal defect and tricuspid regurgitation had been produced beforehand, was heterotopically transplanted into the recipient's chest cavity. In seven dogs, two to three mCi of 111In-antimyosin was injected intravenously upon cardiac rejection before the heart was excised. 111In-antimyosin myocardial imaging was then performed using a gamma camera. In the same slice, a histopathological rejection score was calculated and divided into mild, moderate or severe injection. the uptake of 111In-antimyosin was significantly higher in moderate and severe rejected myocardium, since this agent produced a specific and selective localization and concentration in areas of myocardial damage. Therefore, this new technique allows the evaluation of therapeutic intervention upon cardiac rejection and may replace right ventricular endomyocardial biopsy.
Similar content being viewed by others
References
Baumgarter WA, Reitz BA, Oyer DE, Stinson EB, Shumway NE (1979) Cardiac transplantation. Curr Probl Surg 16:1–61
Caves PK, Stinson EB, Billingham ME, Rider K, Shumway NE (1973) Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg 66:461–464
Copeland JG, Stinson EB (1979) Human heart transplantation. Curr Probl Cardiol 4:4–451
Haverich A, Billingham ME, Scott WC, Jamieson SW, Dawkins KD (1984) Asymmetric pattern of rejection following orthotopic cardiac transplantation in primates. Heart Transplant 3:280–285
Keenan AM, Harbert JC, Larson SM (1985) Monoclonal antibodies in nuclear medicine. J Nucl Med 26:531–537
Khaw BA, Beller GA, Haber E, Smith TW (1976) Localization of cardiac myosin-specific antibody in myocardial infarction. J Clin Invest 58:439–446
Khaw BA, Fallon JT, Beller GA, Haber E (1979) Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Circulation 60:1527–1531
Khaw BA, Fallon JT, Strauss HW, Haber E (1980) Myocardial infarct imaging of antibodies to canine cardiac myosin with Indium-111-Diethylenetriamine pentaacetic acid. Science 209:295–297
Khaw BA, Gold HK, Moore R, Fallon JT, Yasuda T, Leinbach RC, Strauss HW, Haber E (1984) Infarct size after reperfusion by simultaneous intracoronary In-111-monoclonal antimyosin and Tc-99m pyrophosphate comparison by gamma scintigraphy. J Nucl Med 25:69
Larson SM, Carrasquillo JA, Reynolds JC (1984) Radioimmuno-detection and radioimmunotherapy. Cancer Invest 2:363–381
McGregor CGA, Halz R, Azia S, Billingham MB, McDoujall IR (1984) Technetium-99m pyrophosphate scan of acute cardiac rejection in the rat with effects of cyclosporine. J Nucl Med 25:870–873
Novitzky D, Boniaszczuk J, Cooper DKC, Issacs S, Rose AG, Smith JA, Uys CJ, Bernard N (1985) Prediction of cardiac rejection using radionuclide technique. S Afr Med 65:5
Nowygrod R, Spontnitz HM, Du Broff JM, Hardy MA, Reemtma K (1983) Organ Mass: An indicator of heart transplant rejection. Transplant Proc 15:1225
Pinedo JI, Golistin A, Cienfuegos JA, Castillo-Olivaros JL, Eifuerd D, Ortiz Berrocal J (1985) Role of 201Tl in the management of cardiac transplantation. Eur J Nucl Med 10:203–207
Schroeder JS, Popp RL, Stinson EB, Dong E, Shumway NE, Harrison DC (1969) Acute rejection following cardiac transplantation: Phenocardiographic and ultrasound observations. Circulation 15:155–164
Yasuda T, Khaw BA, Gold HK, Moore RH, Fallon JT, Strauss HW, Haber E (1985) Quantification of myocardial necrosis with Tc-99m monoclonal antimyosin Fab and single photon emission tomography. J Nucl Med 24:37
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishimura, T., Sada, M., Sasaki, H. et al. Identification of cardiac rejection in heterotopic heart transplantation using 111In-antimyosin. Eur J Nucl Med 13, 343–347 (1987). https://doi.org/10.1007/BF00252992
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00252992